Longitudinal Heart Failure Medication Use and Adherence Following Left Ventricular Assist Device Implantation in Privately Insured Patients

by Nicholas Y. Tan, Lindsey R. Sangaralingham, Stephanie R. Schilz, Shannon M. Dunlay
Published 2017-10-01

Risk of progression of monoclonal gammopathy of undetermined significance into lymphoplasmacytic malignancies: determining demographic differences in the USA

by Ronald S. Go, Herbert C. Heien, Lindsey R. Sangaralingham, Elizabeth B. Habermann, Nilay D. Shah
Published 2018-03-01

Predictors of Return Visits Among Insured Emergency Department Mental Health and Substance Abuse Patients, 2005–2013

by Sangil Lee, Jeph Herrin, William V. Bobo, Ryan Johnson, Lindsey R. Sangaralingham, Ronna L. Campbell
Published 2017-07-01

Risk of rheumatoid arthritis diagnosis in statin users in a large nationwide US study

by Madeline N. Peterson, Hayley J. Dykhoff, Cynthia S. Crowson, John M. Davis, Lindsey R. Sangaralingham, Elena Myasoedova
Published 2021-09-01

Epidemiology of cardiogenic shock and cardiac arrest complicating non‐ST‐segment elevation myocardial infarction: 18‐year US study

by Saraschandra Vallabhajosyula, Jacob C. Jentzer, Abhiram Prasad, Lindsey R. Sangaralingham, Kianoush Kashani, Nilay D. Shah, Shannon M. Dunlay
Published 2021-06-01

Renal Outcomes in Patients with Systolic Heart Failure Treated With Sacubitril-Valsartan or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker

by Nicholas Y. Tan, MD, MS, Yihong Deng, PhD, Xiaoxi Yao, PhD, MPH, Lindsey R. Sangaralingham, MPH, Nilay D. Shah, PhD, Andrew D. Rule, MD, John C. Burnett, Jr., MD, Shannon M. Dunlay, MD, MS, S. Jeson Sangaralingham, MS, PhD
Published 2021-04-01

Evaluation for clinical benefit of metformin in patients with idiopathic pulmonary fibrosis and type 2 diabetes mellitus: a national claims-based cohort analysis

by Taylor T. Teague, Stephanie R. Payne, Bryan T. Kelly, Timothy M. Dempsey, Rozalina G. McCoy, Lindsey R. Sangaralingham, Andrew H. Limper
Published 2022-04-01

Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation

by Xiaoxi Yao, Neena S. Abraham, Lindsey R. Sangaralingham, M. Fernanda Bellolio, Robert D. McBane, Nilay D. Shah, Peter A. Noseworthy
Published 2016-06-01

Catheter-related complications and mortality of atrial fibrillation ablation following introduction of contact force-sensing technology

by Nilay D Shah, Xiaoxi Yao, Jun Dong, Rebecca Ward, Joseph G Akar, James P Hummel, Lindsey Sangaralingham, Peter A Noseworthy
Published 2020-10-01

Idiopathic pulmonary fibrosis in the United States: time to diagnosis and treatment

by Michelle B. Herberts, Taylor T. Teague, Viengneesee Thao, Lindsey R. Sangaralingham, Henry J. Henk, Kevin T. Hovde, Timothy M. Dempsey, Andrew H. Limper
Published 2023-08-01

Monoclonal Gammopathy of Undetermined Significance

by Ronald S. Go, MD, Herbert C. Heien, MS, Lindsey R. Sangaralingham, MPH, Elizabeth B. Habermann, PhD, Nilay D. Shah, PhD
Published 2017-09-01

Access to primary care and computed tomography use in the emergency department

by M. Fernanda Bellolio, Shawna D. Bellew, Lindsey R. Sangaralingham, Ronna L. Campbell, Daniel Cabrera, Molly M. Jeffery, Nilay D. Shah, Erik P. Hess
Published 2018-03-01

Increased Computed Tomography Utilization in the Emergency Department and Its Association with Hospital Admission

by M. Fernanda Bellolio, Herbert C. Heien, Lindsey R. Sangaralingham, Molly M. Jeffery, Ronna L. Campbell, Daniel Cabrera, Nilay D. Shah, Erik P. Hess
Published 2017-07-01

Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications

by Bryan T. Kelly, Viengneesee Thao, Timothy M. Dempsey, Lindsey R. Sangaralingham, Stephanie R. Payne, Taylor T. Teague, Teng Moua, Nilay D. Shah, Andrew H. Limper
Published 2021-07-01

Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation

by Xiaoxi Yao, Neena S. Abraham, G. Caleb Alexander, William Crown, Victor M. Montori, Lindsey R. Sangaralingham, Bernard J. Gersh, Nilay D. Shah, Peter A. Noseworthy
Published 2016-02-01

Aldosterone Predicts Cardiovascular, Renal, and Metabolic Disease in the General Community: A 4‐Year Follow‐Up

by Alessia Buglioni, Valentina Cannone, S. Jeson Sangaralingham, Denise M. Heublein, Christopher G. Scott, Kent R. Bailey, Richard J. Rodeheffer, Riccardo Sarzani, John C. Burnett Jr
Published 2015-12-01

CD-NP: a novel engineered dual guanylyl cyclase activator with anti-fibrotic actions in the heart.

by Fernando L Martin, S Jeson Sangaralingham, Brenda K Huntley, Paul M McKie, Tomoko Ichiki, Horng H Chen, Josef Korinek, Gerald E Harders, John C Burnett
Published 2012-01-01

Generalizability of the EAST‐AFNET 4 Trial: Assessing Outcomes of Early Rhythm‐Control Therapy in Patients With Atrial Fibrillation

by Jannis Dickow, Paulus Kirchhof, Holly K. Van Houten, Lindsey R. Sangaralingham, Leon H. W. Dinshaw, Paul A. Friedman, Douglas L. Packer, Peter A. Noseworthy, Xiaoxi Yao
Published 2022-06-01

Ischemic Stroke or Systemic Embolism After Transseptal Ablation of Arrhythmias in Patients With Cardiac Implantable Electronic Devices

by Malini Madhavan, Xiaoxi Yao, Lindsey R. Sangaralingham, Samuel J. Asirvatham, Paul A. Friedman, Christopher J. McLeod, Alan M. Sugrue, Christopher V. DeSimone, Peter A. Noseworthy
Published 2016-04-01

Patient Telemedicine Perceptions During the COVID-19 Pandemic Within a Multi-State Medical Institution: Qualitative Study

by Pravesh Sharma, Anthony R Sinicrope, Pamela Sinicrope, Tabetha A Brockman, Nicole M Reinicke, Ian W West, Liana M Wiepert, Amy E Glasgow, Lindsey R Sangaralingham, Ashley L Holland, Christi A Patten
Published 2022-05-01